The global market for Pharmaceutical Testing was valued at US$ 6838 million in the year 2024 and is projected to reach a revised size of US$ 9895 million by 2031, growing at a CAGR of 5.5% during the forecast period.
There are many testing items for pharmaceutical testing, including drug quality testing, drug ingredient testing, drug heavy metal testing, drug adverse reaction testing, drug sealing testing, biological drug testing, drug appearance testing, drug routine testing, drug physical and chemical testing, drug safety testing and drug defect testing, etc. The purpose of pharmaceutical testing is to prevent substandard drugs from entering the market and ensure the safety of drugs.
China Pharmaceutical Testing core manufacturers are WuXi AppTec銆丆TI銆乄eipu銆丳ONY Medicine銆丼GS銆乄uXi Biologics and etc, the top five manufacturers account for about 14% of the Chinese share. Wuxi AppTec has the largest market, with a presence in more than 30 countries worldwide.. In terms of product type, Drug Packaging Material Testing is the largest segment with a share of about 27%. And in terms of application, Finished Drugs and Environment is the largest downstream segment with a share of 38%.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Testing.
The Pharmaceutical Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eurofins
WuXi AppTec
Pace Analytical Services
Catalent
LabCorp (Covance)
PPD
Element (Exova)
ALS Pharmaceutical
Intertek Group
SGS
Boston Analytical
DYNALABS
CTI
Weipu
PONY Medicine
WuXi Biologics
Standard Group
ICAS
APTBIO
Saifu Lab
GBTc
Kerbio
Assure
NIFDC
Frontage
Pharmaron
Segment by Type
Raw Material Testing
Microbiological Testing
Drug Packaging Material Testing
Macromolecule Drug Biological Analysis and Testing
GMP Public System and Equipment Validation Testing
Pharmacovigilance
Other
Segment by Application
CRO
CMO and CDMO
Finished Drugs and Environment
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Raw Material Testing
1.2.3 Microbiological Testing
1.2.4 Drug Packaging Material Testing
1.2.5 Macromolecule Drug Biological Analysis and Testing
1.2.6 GMP Public System and Equipment Validation Testing
1.2.7 Pharmacovigilance
1.2.8 Other
1.3 Market by Application
1.3.1 Global Pharmaceutical Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 CRO
1.3.3 CMO and CDMO
1.3.4 Finished Drugs and Environment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Testing Market Perspective (2020-2031)
2.2 Global Pharmaceutical Testing Growth Trends by Region
2.2.1 Global Pharmaceutical Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Testing Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Testing Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Testing Market Dynamics
2.3.1 Pharmaceutical Testing Industry Trends
2.3.2 Pharmaceutical Testing Market Drivers
2.3.3 Pharmaceutical Testing Market Challenges
2.3.4 Pharmaceutical Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Testing Players by Revenue
3.1.1 Global Top Pharmaceutical Testing Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Testing Revenue Market Share by Players (2020-2025)
3.2 Global Top Pharmaceutical Testing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Testing Revenue
3.4 Global Pharmaceutical Testing Market Concentration Ratio
3.4.1 Global Pharmaceutical Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Testing Revenue in 2024
3.5 Global Key Players of Pharmaceutical Testing Head office and Area Served
3.6 Global Key Players of Pharmaceutical Testing, Product and Application
3.7 Global Key Players of Pharmaceutical Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Testing Breakdown Data by Type
4.1 Global Pharmaceutical Testing Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Testing Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Testing Breakdown Data by Application
5.1 Global Pharmaceutical Testing Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Testing Market Size (2020-2031)
6.2 North America Pharmaceutical Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Testing Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Testing Market Size (2020-2031)
7.2 Europe Pharmaceutical Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Testing Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Testing Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Testing Market Size (2020-2031)
9.2 Latin America Pharmaceutical Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Testing Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Testing Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins
11.1.1 Eurofins Company Details
11.1.2 Eurofins Business Overview
11.1.3 Eurofins Pharmaceutical Testing Introduction
11.1.4 Eurofins Revenue in Pharmaceutical Testing Business (2020-2025)
11.1.5 Eurofins Recent Development
11.2 WuXi AppTec
11.2.1 WuXi AppTec Company Details
11.2.2 WuXi AppTec Business Overview
11.2.3 WuXi AppTec Pharmaceutical Testing Introduction
11.2.4 WuXi AppTec Revenue in Pharmaceutical Testing Business (2020-2025)
11.2.5 WuXi AppTec Recent Development
11.3 Pace Analytical Services
11.3.1 Pace Analytical Services Company Details
11.3.2 Pace Analytical Services Business Overview
11.3.3 Pace Analytical Services Pharmaceutical Testing Introduction
11.3.4 Pace Analytical Services Revenue in Pharmaceutical Testing Business (2020-2025)
11.3.5 Pace Analytical Services Recent Development
11.4 Catalent
11.4.1 Catalent Company Details
11.4.2 Catalent Business Overview
11.4.3 Catalent Pharmaceutical Testing Introduction
11.4.4 Catalent Revenue in Pharmaceutical Testing Business (2020-2025)
11.4.5 Catalent Recent Development
11.5 LabCorp (Covance)
11.5.1 LabCorp (Covance) Company Details
11.5.2 LabCorp (Covance) Business Overview
11.5.3 LabCorp (Covance) Pharmaceutical Testing Introduction
11.5.4 LabCorp (Covance) Revenue in Pharmaceutical Testing Business (2020-2025)
11.5.5 LabCorp (Covance) Recent Development
11.6 PPD
11.6.1 PPD Company Details
11.6.2 PPD Business Overview
11.6.3 PPD Pharmaceutical Testing Introduction
11.6.4 PPD Revenue in Pharmaceutical Testing Business (2020-2025)
11.6.5 PPD Recent Development
11.7 Element (Exova)
11.7.1 Element (Exova) Company Details
11.7.2 Element (Exova) Business Overview
11.7.3 Element (Exova) Pharmaceutical Testing Introduction
11.7.4 Element (Exova) Revenue in Pharmaceutical Testing Business (2020-2025)
11.7.5 Element (Exova) Recent Development
11.8 ALS Pharmaceutical
11.8.1 ALS Pharmaceutical Company Details
11.8.2 ALS Pharmaceutical Business Overview
11.8.3 ALS Pharmaceutical Pharmaceutical Testing Introduction
11.8.4 ALS Pharmaceutical Revenue in Pharmaceutical Testing Business (2020-2025)
11.8.5 ALS Pharmaceutical Recent Development
11.9 Intertek Group
11.9.1 Intertek Group Company Details
11.9.2 Intertek Group Business Overview
11.9.3 Intertek Group Pharmaceutical Testing Introduction
11.9.4 Intertek Group Revenue in Pharmaceutical Testing Business (2020-2025)
11.9.5 Intertek Group Recent Development
11.10 SGS
11.10.1 SGS Company Details
11.10.2 SGS Business Overview
11.10.3 SGS Pharmaceutical Testing Introduction
11.10.4 SGS Revenue in Pharmaceutical Testing Business (2020-2025)
11.10.5 SGS Recent Development
11.11 Boston Analytical
11.11.1 Boston Analytical Company Details
11.11.2 Boston Analytical Business Overview
11.11.3 Boston Analytical Pharmaceutical Testing Introduction
11.11.4 Boston Analytical Revenue in Pharmaceutical Testing Business (2020-2025)
11.11.5 Boston Analytical Recent Development
11.12 DYNALABS
11.12.1 DYNALABS Company Details
11.12.2 DYNALABS Business Overview
11.12.3 DYNALABS Pharmaceutical Testing Introduction
11.12.4 DYNALABS Revenue in Pharmaceutical Testing Business (2020-2025)
11.12.5 DYNALABS Recent Development
11.13 CTI
11.13.1 CTI Company Details
11.13.2 CTI Business Overview
11.13.3 CTI Pharmaceutical Testing Introduction
11.13.4 CTI Revenue in Pharmaceutical Testing Business (2020-2025)
11.13.5 CTI Recent Development
11.14 Weipu
11.14.1 Weipu Company Details
11.14.2 Weipu Business Overview
11.14.3 Weipu Pharmaceutical Testing Introduction
11.14.4 Weipu Revenue in Pharmaceutical Testing Business (2020-2025)
11.14.5 Weipu Recent Development
11.15 PONY Medicine
11.15.1 PONY Medicine Company Details
11.15.2 PONY Medicine Business Overview
11.15.3 PONY Medicine Pharmaceutical Testing Introduction
11.15.4 PONY Medicine Revenue in Pharmaceutical Testing Business (2020-2025)
11.15.5 PONY Medicine Recent Development
11.16 WuXi Biologics
11.16.1 WuXi Biologics Company Details
11.16.2 WuXi Biologics Business Overview
11.16.3 WuXi Biologics Pharmaceutical Testing Introduction
11.16.4 WuXi Biologics Revenue in Pharmaceutical Testing Business (2020-2025)
11.16.5 WuXi Biologics Recent Development
11.17 Standard Group
11.17.1 Standard Group Company Details
11.17.2 Standard Group Business Overview
11.17.3 Standard Group Pharmaceutical Testing Introduction
11.17.4 Standard Group Revenue in Pharmaceutical Testing Business (2020-2025)
11.17.5 Standard Group Recent Development
11.18 ICAS
11.18.1 ICAS Company Details
11.18.2 ICAS Business Overview
11.18.3 ICAS Pharmaceutical Testing Introduction
11.18.4 ICAS Revenue in Pharmaceutical Testing Business (2020-2025)
11.18.5 ICAS Recent Development
11.19 APTBIO
11.19.1 APTBIO Company Details
11.19.2 APTBIO Business Overview
11.19.3 APTBIO Pharmaceutical Testing Introduction
11.19.4 APTBIO Revenue in Pharmaceutical Testing Business (2020-2025)
11.19.5 APTBIO Recent Development
11.20 Saifu Lab
11.20.1 Saifu Lab Company Details
11.20.2 Saifu Lab Business Overview
11.20.3 Saifu Lab Pharmaceutical Testing Introduction
11.20.4 Saifu Lab Revenue in Pharmaceutical Testing Business (2020-2025)
11.20.5 Saifu Lab Recent Development
11.21 GBTc
11.21.1 GBTc Company Details
11.21.2 GBTc Business Overview
11.21.3 GBTc Pharmaceutical Testing Introduction
11.21.4 GBTc Revenue in Pharmaceutical Testing Business (2020-2025)
11.21.5 GBTc Recent Development
11.22 Kerbio
11.22.1 Kerbio Company Details
11.22.2 Kerbio Business Overview
11.22.3 Kerbio Pharmaceutical Testing Introduction
11.22.4 Kerbio Revenue in Pharmaceutical Testing Business (2020-2025)
11.22.5 Kerbio Recent Development
11.23 Assure
11.23.1 Assure Company Details
11.23.2 Assure Business Overview
11.23.3 Assure Pharmaceutical Testing Introduction
11.23.4 Assure Revenue in Pharmaceutical Testing Business (2020-2025)
11.23.5 Assure Recent Development
11.24 NIFDC
11.24.1 NIFDC Company Details
11.24.2 NIFDC Business Overview
11.24.3 NIFDC Pharmaceutical Testing Introduction
11.24.4 NIFDC Revenue in Pharmaceutical Testing Business (2020-2025)
11.24.5 NIFDC Recent Development
11.25 Frontage
11.25.1 Frontage Company Details
11.25.2 Frontage Business Overview
11.25.3 Frontage Pharmaceutical Testing Introduction
11.25.4 Frontage Revenue in Pharmaceutical Testing Business (2020-2025)
11.25.5 Frontage Recent Development
11.26 Pharmaron
11.26.1 Pharmaron Company Details
11.26.2 Pharmaron Business Overview
11.26.3 Pharmaron Pharmaceutical Testing Introduction
11.26.4 Pharmaron Revenue in Pharmaceutical Testing Business (2020-2025)
11.26.5 Pharmaron Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Eurofins
WuXi AppTec
Pace Analytical Services
Catalent
LabCorp (Covance)
PPD
Element (Exova)
ALS Pharmaceutical
Intertek Group
SGS
Boston Analytical
DYNALABS
CTI
Weipu
PONY Medicine
WuXi Biologics
Standard Group
ICAS
APTBIO
Saifu Lab
GBTc
Kerbio
Assure
NIFDC
Frontage
Pharmaron
听
听
*If Applicable.
